R1	Has_qualifier Arg1:T1 Arg2:T3	
R2	Has_qualifier Arg1:T1 Arg2:T2	
R3	Has_qualifier Arg1:T4 Arg2:T5	
R4	Has_qualifier Arg1:T4 Arg2:T6	
R5	Has_temporal Arg1:T4 Arg2:T7	
*	OR T8 T10 T9 T11
R6	Subsumes Arg1:T4 Arg2:T8	
*	OR T30 T31
R7	Has_value Arg1:T29 Arg2:T30	
R8	Has_value Arg1:T33 Arg2:T34	
*	OR T29 T33
R10	Has_multiplier Arg1:T14 Arg2:T15	
R11	Has_multiplier Arg1:T16 Arg2:T17	
R12	Has_multiplier Arg1:T18 Arg2:T19	
R13	Has_multiplier Arg1:T20 Arg2:T21	
R14	Has_multiplier Arg1:T22 Arg2:T23	
R15	Has_multiplier Arg1:T24 Arg2:T25	
R16	Has_multiplier Arg1:T26 Arg2:T27	
*	OR T14 T16 T18 T20 T22 T24 T26
R17	Has_multiplier Arg1:T14 Arg2:T36	
R18	Has_multiplier Arg1:T14 Arg2:T13	
R19	AND Arg1:T28 Arg2:T38	
R9	Subsumes Arg1:T28 Arg2:T29	
R20	AND Arg1:T1 Arg2:T40	
T1	Condition 32 35	OCD
T2	Qualifier 16 23	primary
T3	Qualifier 24 31	DSM- IV
T4	Drug 411 422	medications
T5	Qualifier 400 410	concurrent
T6	Qualifier 375 381	Stable
T7	Temporal 383 398	8 wks or longer
T8	Drug 433 448	benzodiazepines
T9	Drug 450 468	sedative hypnotics
T10	Drug 470 484	antipsychotics
T11	Drug 490 505	antidepressants
T13	Multiplier 53 60	14-week
T14	Drug 106 116	fluoxetine
T15	Multiplier 117 126	80 mg/day
T16	Drug 128 138	paroxetine
T17	Multiplier 139 148	60 mg/day
T18	Drug 150 161	fluvoxamine
T19	Multiplier 162 172	300 mg/day
T20	Drug 174 186	clomipramine
T21	Multiplier 187 197	250 mg/day
T22	Drug 199 209	sertraline
T23	Multiplier 210 220	200 mg/day
T24	Drug 222 232	citalopram
T25	Multiplier 233 242	60 mg/day
T26	Drug 244 256	escitalopram
T27	Multiplier 257 266	30 mg/day
T28	Condition 302 314	responses to
T29	Measurement 330 335	CGI-I
T30	Value 339 340	3
T31	Value 344 345	4
T33	Measurement 347 353	Y-BOCS
T34	Value 354 372	reduction of < 35%
T36	Multiplier 81 98	one the following
T38	Procedure 315 328	SRI treatment
T40	Visit 0 10	Outpatient
